392 related articles for article (PubMed ID: 19408737)
1. [Insulin-like growth factor-binding protein-1: a new biochemical marker of nonalcoholic fatty liver disease?].
Graffigna MN; Belli SH; de Larrañaga G; Fainboim H; Estepo C; Peres S; García N; Levalle O
Acta Gastroenterol Latinoam; 2009 Mar; 39(1):30-7. PubMed ID: 19408737
[TBL] [Abstract][Full Text] [Related]
2. [Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis].
Choi SY; Kim D; Kang JH; Park MJ; Kim YS; Lim SH; Kim CH; Lee HS
Korean J Hepatol; 2008 Mar; 14(1):77-88. PubMed ID: 18367860
[TBL] [Abstract][Full Text] [Related]
3. Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The "VARES" Italian multicenter study.
Grattagliano I; Ubaldi E; Napoli L; Marulli CF; Nebiacolombo C; Cottone C; Portincasa P
Ann Hepatol; 2013; 12(1):70-7. PubMed ID: 23293196
[TBL] [Abstract][Full Text] [Related]
4. Plasma plasminogen activator inhibitor-1 levels and nonalcoholic fatty liver in individuals with features of metabolic syndrome.
de Larrañaga G; Wingeyer SP; Graffigna M; Belli S; Bendezú K; Alvarez S; Levalle O; Fainboim H
Clin Appl Thromb Hemost; 2008 Jul; 14(3):319-24. PubMed ID: 18160600
[TBL] [Abstract][Full Text] [Related]
5. Serum sex hormone-binding globulin levels are independently associated with nonalcoholic fatty liver disease in people with type 2 diabetes.
Shin JY; Kim SK; Lee MY; Kim HS; Ye BI; Shin YG; Baik SK; Chung CH
Diabetes Res Clin Pract; 2011 Oct; 94(1):156-62. PubMed ID: 21862168
[TBL] [Abstract][Full Text] [Related]
6. Irisin in patients with nonalcoholic fatty liver disease.
Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
[TBL] [Abstract][Full Text] [Related]
7. Hepatic steatosis in obese Chinese children.
Chan DF; Li AM; Chu WC; Chan MH; Wong EM; Liu EK; Chan IH; Yin J; Lam CW; Fok TF; Nelson EA
Int J Obes Relat Metab Disord; 2004 Oct; 28(10):1257-63. PubMed ID: 15278103
[TBL] [Abstract][Full Text] [Related]
8. The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease.
Oh SY; Cho YK; Kang MS; Yoo TW; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Son BH; Shin JH
Metabolism; 2006 Dec; 55(12):1604-9. PubMed ID: 17142131
[TBL] [Abstract][Full Text] [Related]
9. Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Verrijken A; Francque S; Mertens I; Prawitt J; Caron S; Hubens G; Van Marck E; Staels B; Michielsen P; Van Gaal L
Hepatology; 2014 Jan; 59(1):121-9. PubMed ID: 24375485
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence of nonalcoholic fatty liver disease and metabolic syndrome in obese children].
Shi HB; Fu JF; Liang L; Wang CL; Zhu JF; Zhou F; Zhao ZY
Zhonghua Er Ke Za Zhi; 2009 Feb; 47(2):114-8. PubMed ID: 19573457
[TBL] [Abstract][Full Text] [Related]
11. Low Serum Sex Hormone-Binding Globulin Associated with Insulin Resistance in Men with Nonalcoholic Fatty Liver Disease.
Ye J; Yao Z; Tan A; Gao Y; Chen Y; Lin X; He R; Tang R; Hu Y; Zhang H; Yang X; Wang Q; Jiang Y; Mo Z
Horm Metab Res; 2017 May; 49(5):359-364. PubMed ID: 28282659
[TBL] [Abstract][Full Text] [Related]
12. Hepatic steatosis rather than visceral adiposity is more closely associated with insulin resistance in the early stage of obesity.
Wasada T; Kasahara T; Wada J; Jimba S; Fujimaki R; Nakagami T; Iwamoto Y
Metabolism; 2008 Jul; 57(7):980-5. PubMed ID: 18555841
[TBL] [Abstract][Full Text] [Related]
13. Serum concentrations of human insulin-like growth factor-1 and levels of insulin-like growth factor-binding protein-5 in patients with nonalcoholic fatty liver disease: association with liver histology.
Colak Y; Senates E; Ozturk O; Yilmaz Y; Zemheri E; Yilmaz Enc F; Ulasoglu C; Aksaray S; Bozbeyoglu SG; Kiziltas S; Kurdas OO; Tuncer I
Eur J Gastroenterol Hepatol; 2012 Mar; 24(3):255-61. PubMed ID: 22157234
[TBL] [Abstract][Full Text] [Related]
14. Serum adipocyte fatty acid-binding protein levels are associated with nonalcoholic fatty liver disease in type 2 diabetic patients.
Koh JH; Shin YG; Nam SM; Lee MY; Chung CH; Shin JY
Diabetes Care; 2009 Jan; 32(1):147-52. PubMed ID: 18835952
[TBL] [Abstract][Full Text] [Related]
15. Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children.
Yoo J; Lee S; Kim K; Yoo S; Sung E; Yim J
Diabetes Res Clin Pract; 2008 Sep; 81(3):321-6. PubMed ID: 18571268
[TBL] [Abstract][Full Text] [Related]
16. Nonalcoholic fatty liver disease in severely obese subjects.
Gholam PM; Flancbaum L; Machan JT; Charney DA; Kotler DP
Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
[TBL] [Abstract][Full Text] [Related]
17. The relationship between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in non-obese non-diabetic Turkish individuals: A pilot study.
Erkan G; Sayın I; Polat FB; Çorakçı A; Ataç GK; Değertekin H
Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():63-8. PubMed ID: 25910371
[TBL] [Abstract][Full Text] [Related]
18. Relationships between estimates of adiposity, insulin resistance, and nonalcoholic fatty liver disease in a large group of nondiabetic Korean adults.
Sung KC; Ryan MC; Kim BS; Cho YK; Kim BI; Reaven GM
Diabetes Care; 2007 Aug; 30(8):2113-8. PubMed ID: 17475935
[TBL] [Abstract][Full Text] [Related]
19. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.
Portillo-Sanchez P; Bril F; Maximos M; Lomonaco R; Biernacki D; Orsak B; Subbarayan S; Webb A; Hecht J; Cusi K
J Clin Endocrinol Metab; 2015 Jun; 100(6):2231-8. PubMed ID: 25885947
[TBL] [Abstract][Full Text] [Related]
20. Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity.
Fracanzani AL; Valenti L; Bugianesi E; Vanni E; Grieco A; Miele L; Consonni D; Fatta E; Lombardi R; Marchesini G; Fargion S
J Hepatol; 2011 Jun; 54(6):1244-9. PubMed ID: 21145841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
